leisure time -WSS

leisure time

author：hotspot 2025-10-02 14:57:22 - browse：67746

A psilocybin mushroom lays inside a clear capsule — Adobe

A single dose of psilocybin may have enduring benefits for people with major depressive disorder, according to a randomized clinical trial published Thursday in the Journal of the American Medical Association.

Several prior studies have suggested that psilocybin, the psychedelic compound produced by certain types of mushrooms, could be a promising way to treat major depression in people for whom antidepressants or counseling aren’t effective. But those studies mostly focused on short-term results, while the new JAMA study looked at psilocybin’s efficacy up to six weeks after the administration of a single dose of psilocybin.

“It’s exciting to see another study that’s coming out that is adding to the evidence base suggesting potential efficacy of psilocybin for depression, amongst other conditions,” said Greg Fonzo, an assistant professor and co-director for the Center for Psychedelic Research and Therapy at the University of Texas at Austin’s Dell Medical School, who was not involved in the study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： New Alzheimer's drugs heat up race for early detection blood tests

WSS

Eisai exec who led development of Alzheimer’s drug to retire

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

What to watch for from Zogenix and Amicus clinical trials

Rise in cancer among younger people worries and puzzles doctors

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

Why patients can’t get everything they want on drug pricing

leisure time

leisure time

focus

Sports medicine is finally prioritizing gender equality

Teachers share how revamped forgiveness program helped with their student loans

Malaria cases in Florida and Texas: Here’s what you need to know

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Tori Bowie and the unacceptable rates of Black maternal death

The U.S. needs a new definition of substance use “recovery”

Moonlake's readout produced a cash windfall. Risks remain

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

What it's like to live with paralysis for one psychologist

Wikipedia

Eisai exec who led development of Alzheimer’s drug to retire

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

The U.S. needs a new definition of substance use “recovery”

ACA's risk program benefits Blue Cross Blue Shield insurers

Truvian presents data for its desktop blood

Medicare wants to send $9 billion to 340B hospitals

knowledge

explore

knowledge

hotspot